Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mono-Center Phase ǀ Study on Dose Escalation of Stereotactic Body Radiotherapy (SBRT) Treating Pancreatic Cancer Patients With CyberKnife

NCT02716207 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT02716207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02716207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mono-Center Phase ǀ Study on Dose Escalation of Stereotactic Body Radiotherapy (SBRT) Treating Pancreatic Cancer Patients With CyberKnife
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2016
Completion date
December 31, 2020
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic tumor